MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
63.00
-3.39 (-5.11%)
Aug 28, 2026, 4:00 PM EDT - Market closed
MBX Biosciences Employees
MBX Biosciences had 63 employees as of December 31, 2025. The number of employees increased by 20 or 46.51% compared to the previous year.
Employees
63
Change (1Y)
20
Growth (1Y)
46.51%
Revenue / Employee
n/a
Profits / Employee
-$1,655,429
Market Cap
3.03B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 63 | 20 | 46.51% |
| Dec 31, 2024 | 43 | 16 | 59.26% |
| Sep 30, 2024 | 38 | 11 | 40.74% |
| Jun 30, 2024 | 36 | - | - |
| Mar 31, 2024 | 28 | - | - |
| Dec 31, 2023 | 27 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Beam Therapeutics | 540 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Structure Therapeutics | 281 |
| Immunome | 247 |
| Alumis | 239 |
| uniQure | 221 |
MBX News
- 2 days ago - MBX Biosciences doses first patient in oPTimize clinical trial - TheFly
- 2 days ago - MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism - GlobeNewsWire
- 8 days ago - MBX Biosciences reinstated with an Overweight at JPMorgan - TheFly
- 19 days ago - MBX Biosciences price target raised to $88 from $70 at Truist - TheFly
- 22 days ago - MBX Biosciences price target raised to $88 from $70 at Barclays - TheFly
- 23 days ago - MBX Biosciences reports Q2 EPS (78c), consensus (59c) - TheFly
- 23 days ago - MBX Biosciences Earnings release: Q2 2026 - Filings
- 23 days ago - MBX Biosciences Quarterly report: Q2 2026 - Filings